Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Tributyrin, a triglyceride form of butyric acid, is sometimes used as a supplement to support gut health, including conditions described as "Leaky Gut Syndrome" (increased intestinal permeability). The scientific basis for its use is derived from research on butyrate, a short-chain fatty acid produced by gut microbiota during the fermentation of dietary fibers. Butyrate serves as the primary energy source for colonocytes (cells lining the colon) and has been shown in various in vitro and animal studies to enhance intestinal barrier function, reduce inflammation, and promote the production of tight junction proteins that help maintain gut integrity.

A few animal studies and some preliminary human data suggest that butyrate supplementation (and by extension, tributyrin, which is a prodrug for butyrate) may help restore intestinal barrier function and reduce gut inflammation. For example, studies in mice have shown that tributyrin can decrease intestinal permeability and improve outcomes in models of colitis or chemically-induced gut injury. Human data are limited, with most clinical studies focusing on broader inflammatory bowel conditions rather than "Leaky Gut Syndrome" per se. The term "Leaky Gut Syndrome" itself is not widely recognized as a formal medical diagnosis, which complicates the evidence base.

Overall, while some mechanistic and early clinical evidence exists to support the rationale for tributyrin supplementation in improving gut barrier function, robust clinical trials in humans with "Leaky Gut Syndrome" are lacking. Thus, the evidence is preliminary and rates as moderate to low (2/5) for this specific indication.

More about tributyrin
More about Leaky Gut Syndrome

Other ingredients used for Leaky Gut Syndrome

Other health conditions supported by tributyrin

Products containing tributyrin